SHAREHOLDERS` EQUITY (Details) - Stock options outstanding under the 2018 - 2018 Share Plan [Member] - Range Of Exercise Prices $3.70 To $4.61 [Member] |
12 Months Ended |
|---|---|
|
Oct. 31, 2018
$ / shares
shares
| |
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
| Options Outstanding, Number | shares | 3,482,000 |
| Options Outstanding,Weighted Average Remaining Contractual Life | 9 years 189 days |
| Options Outstanding, Weighted Average Exercise Price | $ / shares | $ 3.73 |
| Options Exercisable, Number | shares | 828,611 |
| Options Exercisable,Weighted Average Remaining Contractual Life | 9 years 189 days |
| Options Exercisable, Weighted Average Exercise Price | $ / shares | $ 3.71 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|